Drug Profile
LY 2590443
Alternative Names: LY2590443Latest Information Update: 29 Dec 2009
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Antimigraines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 11 Dec 2008 Preclinical trials in Migraine in USA (PO)